| Financial Year |
March 31 2023 |
| Monetary Funds |
830,137,410.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
405,780.37 |
| Accounts Receivable |
303,044,372.08 |
| Advances to Suppliers |
172,001,678.79 |
| Other Receivables |
140,475,837.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,232,722,799.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,970,845.30 |
| Total Current Assets |
3,727,758,723.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
202,913,708.49 |
| Investment Properties |
15,653,988.76 |
| Fixed Assetes |
2,004,874,846.57 |
| Under-construction Projects |
191,113,244.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
608,504,561.06 |
| R&D expenses |
-- |
| Goodwill |
63,761,307.20 |
| Long-Term Deferred and Prepaid Expenses |
847,550,329.26 |
| Deferred Income Tax Assets |
508,574,948.46 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
6,109,750,193.60 |
| Total Assets |
9,837,508,917.22 |
| Short-Term Loans |
1,016,047,487.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
506,507,837.96 |
| Accounts Payable |
338,755,485.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
61,512,807.89 |
| Taxes Payable |
38,784,843.23 |
| Interest Payable |
3,438,888.60 |
| Dividend Payable |
-- |
| Other payables |
33,992,877.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
566,278,984.93 |
| Other Current Liabilities |
5,922,659.02 |
| Sub-Total of Current Liabilities |
2,673,264,386.93 |
| Long-term Loans |
1,243,061,769.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
278,452,592.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,038,250,258.75 |
| Total Liabilities |
5,711,514,645.68 |
| Paid-In Capital(Or Share Stock) |
1,495,944,883.00 |
| Capital Surplus |
250,871,705.72 |
| Surplus Reserve |
384,429,529.42 |
| LESS:Treasury Stock |
28,363,926.80 |
| Undistributed Profits |
1,990,748,742.53 |
| Minority Stockholder's Interest |
18,740,403.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,107,253,867.97 |
| Owner's Equity（Stockholder's Equity） |
4,125,994,271.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,837,508,917.22 |
